Mutant allele frequency predicts the efficacy of EGFR-TKIs in lung adenocarcinoma harboring the L858R mutation.
Ann Oncol
; 25(10): 1948-1953, 2014 Oct.
Article
in En
| MEDLINE
| ID: mdl-25009007
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Adenocarcinoma
/
Protein Kinase Inhibitors
/
ErbB Receptors
/
Lung Neoplasms
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Ann Oncol
Journal subject:
NEOPLASIAS
Year:
2014
Document type:
Article
Country of publication:
United kingdom